SUNSHINE PHARMA(06887): Hong Kong Stock Exchange grants approval for the full circulation of H shares listing.
Dongyang Guangyao (06887) announces that the Stock Exchange has granted listing approval and permission to trade 208 million H shares converted from domestic shares according to the full circulation and conversion of H shares in 2026 on May 5. The conversion and listing will involve a total of 29 participating shareholders of the company, totaling 208 million domestic shares, accounting for approximately 36.14% of the total issued capital of the company on the date of this announcement (including treasury shares).
Sunshine Pharma (06887) announced that the Stock Exchange has granted approval for the listing and permission to trade 2.08 billion H shares converted from domestic shares under the H-share full circulation and conversion listing. The conversion and listing involve a total of 29 participating shareholders of the company, totaling 2.08 billion domestic shares, representing approximately 36.14% of the total issued share capital of the company as of the date of this announcement.
Related Articles
Investment establishment of Chongqing Xinghui Electric Motor Co., Ltd. by Chongqing Xishan Science & Technology (688576.SH)
Zuoli M-FIN (06866): Controlling shareholder Puhua Energy intends to acquire 0.2443% equity stake in Jinhui microfinance.
Yongda Auto (03669) spent approximately HKD $818,500 to repurchase 800,000 shares on May 6th.
Investment establishment of Chongqing Xinghui Electric Motor Co., Ltd. by Chongqing Xishan Science & Technology (688576.SH)
Zuoli M-FIN (06866): Controlling shareholder Puhua Energy intends to acquire 0.2443% equity stake in Jinhui microfinance.
Yongda Auto (03669) spent approximately HKD $818,500 to repurchase 800,000 shares on May 6th.
